Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Kestra Medical Technologies, Ltd. publishes a filing, an earnings call transcript or a press release.

Get KMTS alerts

About Brian Webster

Brian Webster is recorded as Board Member and CEO at Kestra Medical Technologies, Ltd. (KMTS). The newest filing on record that lists Brian Webster as Board Member and CEO at Kestra Medical Technologies, Ltd. (KMTS) is dated July 28, 2026. The proxy statement of Kestra Medical Technologies, Ltd. reports total compensation of $7,501,904 for Brian Webster in fiscal 2026, including a base salary of $765,000. Disclosed compensation is on record for 3 fiscal years. Brian Webster has spoken on 4 earnings calls across 1 company, most recently for Kestra Medical Technologies, Ltd. on July 14, 2026. Kestra Medical Technologies, Ltd. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Kestra Medical Technologies, Ltd. includes Vaseem Mahboob (CFO), Traci S. Umberger (General Counsel and Board Member) and Conor Hanley (Board Member).

Brian Webster on recent calls

“We are excited to discuss the details of our strong performance in the fourth quarter and the significant progress KESTRA made in fiscal 2026. As always, I'd like to begin the call by focusing on what truly differentiates KESTRA.”
CEO, Kestra Medical Technologies, Ltd. Q4 FY2026 Earnings Call ·
“Happy St. Patrick's Day to all of our friends in Ireland. We are an Irish domiciled company, so we're happy to celebrate along with them. We're excited to discuss the strong financial performance we had in the third quarter and the continued progress we were making on our key operational objectives.”
CEO, Kestra Medical Technologies, Ltd. Q3 FY2026 Earnings Call ·
“We are excited to discuss the strong financial performance we had in the second quarter and the continued progress we are making on our key operational objectives.”
CEO, Kestra Medical Technologies, Ltd. Q2 FY2026 Earnings Call ·
“We are excited to discuss the strong start we had to our fiscal '26 and the continued progress we have made in our key operational objectives. But before we jump into that, I'd like to again highlight the purpose behind the mission that drives the Kestra team.”
CEO, Kestra Medical Technologies, Ltd. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Kestra Medical Technologies, Ltd.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 Kestra Medical Technologies, Ltd. (KMTS) $765,000 $7,501,904
2025 Kestra Medical Technologies, Ltd. (KMTS) $589,098 $18,890,730
2024 Kestra Medical Technologies, Ltd. (KMTS) $522,535 $757,564

Recent activity